Target Name: MIER3
NCBI ID: G166968
Review Report on MIER3 Target / Biomarker Content of Review Report on MIER3 Target / Biomarker
MIER3
Other Name(s): Mi-er3 | Mesoderm induction early response protein 3 (isoform 3) | MIER family member 3 | MIER3 variant 3 | mesoderm induction early response 1, family member 3 | MIER3_HUMAN | Mesoderm induction early response protein 3 | mi-er3 | Mesoderm induction early response 3

MIER3: A Drug Target / Disease Biomarker

MIER3 (Melanoma-Induced Enhanced Responsiveness to Radiation) is a protein that is expressed in high levels in melanoma cells. It has been shown to be a potential drug target for melanoma treatment.

MIER3 is a transmembrane protein that is involved in the regulation of cell signaling pathways. It is a member of the TGF-β (Transforming Growth Factor-尾) family, which is known for its role in cell growth, differentiation, and survival.

Melanoma is a type of skin cancer that is highly aggressive and can be difficult to treat. The development of melanoma is thought to be caused by a combination of genetic and environmental factors, including exposure to sun radiation.

MIER3 has been shown to be involved in the regulation of the TGF-β signaling pathway. It has been shown to play a role in the development and progression of melanoma.

One of the key findings of recent studies has been the involvement of MIER3 in the development of metastatic melanoma. Studies have shown that high levels of MIER3 are associated with the development of metastatic melanoma, and that inhibition of MIER3 has been shown to be effective in melanoma treatment.

In addition to its role in the development of metastatic melanoma, MIER3 has also been shown to be involved in the regulation of cell survival. Studies have shown that high levels of MIER3 are associated with increased cell survival, which can make it more difficult to treat melanoma.

The potential drug targets for MIER3 are still being explored, but it is clear that it is an important protein in the development and progression of melanoma. Further research is needed to fully understand the role of MIER3 in melanoma and to develop effective treatments.

In conclusion, MIER3 is a protein that is expressed in high levels in melanoma cells and has been shown to be involved in the regulation of cell signaling pathways. It is a potential drug target for melanoma treatment and further research is needed to fully understand its role in the development and progression of melanoma.

Protein Name: MIER Family Member 3

Functions: Transcriptional repressor

The "MIER3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIER3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIF | MIF-AS1 | MIF4GD | MIGA1 | MIGA2 | MIIP | MILIP | MILR1 | MIMT1 | MINAR1 | MINAR2 | MINCR | MINDY1 | MINDY2 | MINDY2-DT | MINDY3 | MINDY4 | Minichromosome maintenance (MCM) 2-7 helicase complex | MINK1 | MINPP1 | MIOS | MIOX | MIP | MIPEP | MIPEPP3 | MIPOL1 | MIR1-1 | MIR1-1HG | MIR1-2 | MIR100 | MIR100HG | MIR101-1 | MIR101-2 | MIR10394 | MIR10396B | MIR10399 | MIR103A1 | MIR103A2 | MIR103B1 | MIR103B2 | MIR105-1 | MIR105-2 | MIR10527 | MIR106A | MIR106B | MIR107 | MIR10A | MIR10B | MIR11181 | MIR11400 | MIR11401 | MIR1178 | MIR1179 | MIR1180 | MIR1181 | MIR1182 | MIR1183 | MIR1184-1 | MIR1184-2 | MIR1184-3 | MIR1185-1 | MIR1185-2 | MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A